High Net Worth Advisory Group’s Avidity Biosciences RNAM Stock Holding History

High Net Worth Advisory Group’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,500	Closed	-$252K	–	251
2025 Q4	$252K	Buy	+3,500	New	+$226K	0.06%	210

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

High Net Worth Advisory Group's RNAM Position: Q1 2026 in Review

High Net Worth Advisory Group sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 3,500 shares — an estimated $252K sold.

High Net Worth Advisory Group first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $252K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

High Net Worth Advisory Group reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
High Net Worth Advisory Group sold 3,500 Avidity Biosciences shares in Q1 2026, an estimated $252K.
High Net Worth Advisory Group first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
High Net Worth Advisory Group's Avidity Biosciences position peaked at $252K in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on High Net Worth Advisory Group's 13F filing for Q1 2026, filed 17 Apr 2026.